Preston Klassen

Preston S.
Klassen worked at Amgen, Inc. as Executive Director-Medical from 2002 to 2009.
From 2009 to 2016, worked at Orexigen Therapeutics, Inc. as Executive VP & Head-Global Development.
Served as President & Chief Medical Officer at Sanifit Therapeutics SA from 2016 to 2017.
Held the position of Chief Medical Officer, Executive VP, Head-R&D at Arena Pharmaceuticals, Inc. from 2017 to 2020.
Was President, Chief Executive Officer & Director at Metacrine, Inc. from 2020 to 2023.
Served as President & Chief Operating Officer at Zura Bio Ltd. in 2023.
Held the role of President, Director & Head-Research & Development at Regulus Therapeutics, Inc. from 2023 to 2025.
Served as Independent Director at Conatus Pharmaceuticals, Inc. from 2014 to 2020.
Held director positions at Corvidia Therapeutics, Inc., Equillium, Inc., and Chinook Therapeutics, Inc. Also served as President & Chief Marketing Officer at Sanifit, Inc. Education includes a doctorate from the University of Nebraska Medical Center, an undergraduate degree from Central College, and a graduate degree from Duke University conferred in 2000.